The lie of the land: extending exclusivity for pharmaceuticals and biotech
Market exclusivity is a key incentive for pharmaceutical, agrichemical and biologics innovator companies to assume the enormous risks associated with their investments in R&D and marketing: once a new product comes to market, meaningful profits are possible only through at least some period of exclusive rights for the product.
